ArticleCancer research communications2026

Dissociated Response to Immune Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma Is Common and Exhibits Distinct Clinical Outcomes.

Alice N Weaver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.